Ketoprofen versus Paracetamol (Acetaminophen) or Ibuprofen in the Management of Fever Results of Two Randomized, Double-Blind, Double-Dummy, Parallel-Group, Repeated-Dose, Multicentre, Phase III Studies in Children

被引:0
|
作者
Kokki, Hannu
Kokki, Merja
机构
[1] Univ Eastern Finland, Dept Anesthesiol & Intens Care, Kuopio, Finland
[2] Kuopio Univ Hosp, SF-70210 Kuopio, Finland
关键词
PRESCHOOL-CHILDREN; PARENTS;
D O I
10.1007/BF03256907
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Fever is a common symptom in children and one of the major concerns of parents of younger and preschool-age children. Objective: To compare the efficacy and safety of ketoprofen with that of paracetamol (acetaminophen) and ibuprofen in the treatment of febrile conditions in children. Methods: Two prospective, randomized, double-blind, double-dummy, repeated-dose, multicentre, phase III studies with two parallel groups in each study were conducted in primary-care outpatient clinics. Children aged 6 months to 6 years presenting with a febrile condition and an oral body temperature of >= 38.8 degrees C or rectal temperature of >= 39 degrees C were eligible for inclusion. Patients were randomized to receive either ketoprofen syrup 0.5 mg/kg, ibuprofen suspension 5 mg/kg or paracetamol suspension 15 mg/kg every 6 hours by the oral route. The primary outcome measure was the change in temperature at 3 hours (H3), compared with baseline (H0). Results: All three treatments provided similar mean maximum decreases of 1.4-1.5 degrees C in body temperature at H3 compared with H0. Use of ketoprofen was not associated with any increased risk of adverse events compared with the two reference compounds. Conclusion: Ketoprofen 0.5 mg/kg appeared to be equivalent to the standard antipyretic doses of the reference products ibuprofen 5 mg/kg and paracetamol 15 mg/kg. Ketoprofen at the 0.5 mg/kg dose should be an effective and safe option for symptomatic management of fever in children.
引用
收藏
页码:375 / 386
页数:12
相关论文
共 50 条
  • [1] Ketoprofen versus Paracetamol (Acetaminophen) or Ibuprofen in the Management of FeverResults of Two Randomized, Double-Blind, Double-Dummy, Parallel-Group, Repeated-Dose, Multicentre, Phase III Studies in Children
    Hannu Kokki
    Merja Kokki
    [J]. Clinical Drug Investigation, 2010, 30 : 375 - 386
  • [2] Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study
    Maspero, Jorge
    Guerra, Frances
    Cuevas, Francisco
    Gutierrez, Jose Pablo
    Soto-Ramos, Mario
    Anderton, Sally
    Mechali, Daniel
    Chan, Robert
    Pedersen, Soren
    [J]. CLINICAL THERAPEUTICS, 2008, 30 (08) : 1492 - 1504
  • [3] Comparison of topiroxostat and allopurinol in Japanese hyperuricemic patients with or without gout: a phase 3, multicentre, randomized, double-blind, double-dummy, active-controlled, parallel-group study
    Hosoya, T.
    Ogawa, Y.
    Hashimoto, H.
    Ohashi, T.
    Sakamoto, R.
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2016, 41 (03) : 290 - 297
  • [4] The efficacy and safety of pramipexole ER versus IR in Chinese patients with Parkinson's disease: A randomized, double-blind, double-dummy, parallel-group study
    Wang Y.
    Sun S.
    Zhu S.
    Liu C.
    Liu Y.
    Di Q.
    Shang H.
    Ren Y.
    Lu C.
    Gordon M.F.
    Juhel N.
    Chen S.
    [J]. Translational Neurodegeneration, 3 (1)
  • [5] Topiramate Versus Amitriptyline in Migraine Prevention: A 26-Week, Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Noninferiority Trial in Adult Migraineurs
    Dodick, David W.
    Freitag, Fred
    Banks, James
    Saper, Joel
    Xiang, Jim
    Rupnow, Marcia
    Biondi, David
    Greenberg, Steven J.
    Hulihan, Joseph
    [J]. CLINICAL THERAPEUTICS, 2009, 31 (03) : 542 - 559
  • [6] Effectiveness and tolerability of once-daily nimesulide versus ibuprofen in pain management after surgical extraction of an impacted third molar:: A 24-hour, double-blind, randomized, double-dummy, parallel-group study
    Bocanegra, M
    Seiias, A
    Yibirín, MG
    [J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2005, 66 (03): : 172 - 180
  • [7] Linagliptin as add-on to empagliflozin and metformin in patients with type 2 diabetes: Two 24-week randomized, double-blind, double-dummy, parallel-group trials
    Tinahones, Francisco J.
    Gallwitz, Baptist
    Nordaby, Matias
    Goetz, Sophia
    Maldonado-Lutomirsky, Mario
    Woerle, Hans J.
    Broedl, Uli C.
    [J]. DIABETES OBESITY & METABOLISM, 2017, 19 (02): : 266 - 274
  • [8] Results of a multicenter, 8-week, parallel-group, randomized, double-blind, double-dummy, phase III clinical trial to evaluate the efficacy and tolerability of amlodipine maleate versus amlodipine besylate in Korean patients with mild to moderate hypertension
    Park, S
    Chung, N
    Kwon, J
    Yoon, JH
    Kim, YJ
    Han, DS
    Kim, HS
    [J]. CLINICAL THERAPEUTICS, 2005, 27 (04) : 441 - 450
  • [9] Safety of Ozanimod Versus Interferon β-1a in Two Multicenter, Randomized, Double-Blind, Parallel-Group, Active-Controlled, Double-Dummy Phase 3 Studies in Relapsing Multiple Sclerosis (SUNBEAM and RADIANCE Part B)
    Cree, Bruce
    Bar-Or, Amit
    Comi, Giancarlo
    Selmaj, Krzysztof
    Arnold, Douglas
    Steinman, Lawrence
    Hartung, Hans-Peter
    Montalban, Xavier
    Havrdova, Eva
    Sheffield, James
    Raghupathi, Kartik
    Kappos, Ludwig
    Cohen, Jeffrey
    [J]. NEUROLOGY, 2018, 90
  • [10] Antipyretic Efficacy and Safety of Ibuprofen Versus Acetaminophen Suspension in Febrile Children: Results of 2 Randomized, Double-Blind, Single-Dose Studies
    Jayawardena, Shyamalie
    Kellstein, David
    [J]. CLINICAL PEDIATRICS, 2017, 56 (12) : 1120 - 1127